AA
JAZZ icon

Ancora Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ancora Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19K Sell
34
-126
-79% -$27.6K ﹤0.01% 1528
2026
Q1 		$30.2K Buy
160
+7
+5% +$1.22K ﹤0.01% 1351
2025
Q4 		$26K Buy
153
+119
+350% +$18.2K ﹤0.01% 1428
2025
Q3 		$4.48K Hold
34
– – ﹤0.01% 1519
2025
Q2 		$3.61K Hold
34
– – ﹤0.01% 1542
2025
Q1 		$4.22K Hold
34
– – ﹤0.01% 1451
2024
Q4 		$4.19K Hold
34
– – ﹤0.01% 1490
2024
Q3 		$3.79K Hold
34
– – ﹤0.01% 1485
2024
Q2 		$3.63K Hold
34
– – ﹤0.01% 1493
2024
Q1 		$4.09K Buy
+34
New +$4.17K ﹤0.01% 1474
2023
Q4 		– Sell
-55
Closed -$7.12K – 1798
2023
Q3 		$7.12K Hold
55
– – ﹤0.01% 1347
2023
Q2 		$6.82K Hold
55
– – ﹤0.01% 1336
2023
Q1 		$8.05K Hold
55
– – ﹤0.01% 1322
2022
Q4 		$9K Sell
55
-75
-58% -$11K ﹤0.01% 1362
2022
Q3 		$17K Sell
130
-13
-9% -$1.98K ﹤0.01% 1380
2022
Q2 		$22K Buy
143
+13
+10% +$2K ﹤0.01% 1409
2022
Q1 		$20K Hold
130
– – ﹤0.01% 1550
2021
Q4 		$17K Hold
130
– – ﹤0.01% 1638
2021
Q3 		$17K Buy
130
+104
+400% +$15.7K ﹤0.01% 1530
2021
Q2 		$5K Buy
+26
New +$4.5K ﹤0.01% 1700

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ancora Advisors's JAZZ Position: Q2 2026 in Review

Ancora Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 79% in Q2 2026, selling an estimated $27.6K and leaving 34 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Ancora Advisors first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $30.2K in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Ancora Advisors held 34 shares of Jazz Pharmaceuticals worth $8.19K as of Q2 2026.
  • Ancora Advisors sold 126 Jazz Pharmaceuticals shares in Q2 2026, an estimated $27.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1528 holding.
  • Ancora Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Ancora Advisors's Jazz Pharmaceuticals position peaked at $30.2K in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.